Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 467
Immune Disorders Drugs 194
Cardiovascular Drugs 156
Biopharmaceuticals 133
Infectious Diseases Drugs 124
Drug Discovery 107
Central Nervous System Drugs 106
Endocrine and Metabolic Disorders Drugs 103
Clinical Trials 98
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 89
Leukemia Drugs 83
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 65
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Respiratory Drugs 39
Immunosuppressive Drugs 37
Gastrointestinal Drugs 33
Infusions and Injectables 32
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 28
Bladder Cancer Drugs 26
Analgesics 26
Drugs by Therapeutic Area 24
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Prostate Cancer Drugs 17
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Vitamins and Dietary Supplements 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,397 Results (Page 12 of 120)
- Relevance
  Sort by

Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2025

 Report
September 2025
450 Pages
Global

From

€3520EUR$3,995USD£3,092GBP

Collaboration Deals in Pharmaceuticals 2020-2025

 Report
September 2025
950 Pages
Global

From

€4402EUR$4,995USD£3,866GBP

Kidney Cancer (Renal Cell Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
322 Pages
Global

From

€2203EUR$2,500USD£1,935GBP

Global Antibiotics Market - Distribution by Type of Drug Class, Target Disease Indication, Type of Therapy (Monotherapies and Combination Therapies), Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

 Report
April 2023
175 Pages
Global

From

€5198EUR$5,899USD£4,566GBP

Cytotoxic Drugs & HPAPI Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Product, Company Size, Scale of Operation, Type of Molecule, Type of Highly Potent Finished Dosage Form and Key Geographies

 Report
October 2025
442 Pages
Global

From

€4229EUR$4,799USD£3,714GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Anxiety Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

 Report
November 2023
190 Pages
Global

From

€3965EUR$4,500USD£3,483GBP

Hepatocellular Carcinoma Drugs - Global Strategic Business Report

 Report
December 2025
198 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Liver Cancer Drugs - Global Strategic Business Report

 Report
December 2025
277 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

US Kidney Cancer Therapeutics and Diagnostics Market to 2028

 Report
October 2023
85 Pages
United States

From

€4274EUR$4,850USD£3,754GBP

Brain Tumor Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3957EUR$4,490USD£3,475GBP

Liver Cancer Drug Market Size, Share & Trends Analysis Report by Therapy (Targeted Therapy, Immunotherapy, Chemotherapy), Type (Hepatocellular Carcinoma), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), Region, and Segment Forecasts 2025-2030

 Report
February 2025
100 Pages
Global

From

€5243EUR$5,950USD£4,605GBP

Immunosuppressants - Global Strategic Business Report

 Report
December 2025
349 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Hepatitis C Treatment Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application

 Report
February 2022
87 Pages
Global

From

€3200EUR$3,890USD£2,909GBP

Urinary Tract Infection Therapeutics Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

 Report
October 2023
172 Pages
Global

From

€3965EUR$4,500USD£3,483GBP

Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1560 Pages
Global

From

€2203EUR$2,500USD£1,935GBP

Glioblastoma Multiforme Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
120 Pages
Global

From

€4186EUR$4,750USD£3,677GBP

Progressive Multifocal Leukoencephalopathy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
January 2024
208 Pages
Global

€4402EUR$4,995USD£3,866GBP

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025

 Report
September 2025
750 Pages
Global

From

€3520EUR$3,995USD£3,092GBP

Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2025

 Report
September 2025
250 Days
Global

From

€3520EUR$3,995USD£3,092GBP

Bladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
November 2022
1018 Pages
Global

From

€2203EUR$2,500USD£1,935GBP

2,397 Results (Page 12 of 120)
- 1
- 10
- 11
- 12
- 13
- 14

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.